Vertex Corp. (5290) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Vertex Corp. (5290:JPX), powered by AI.
- Current Price
- ¥1,409
- P/E Ratio
- 14.8
- Market Cap
- 71.4B
- Sector
- Basic Materials
What is the Vertex Corp. stock price forecast?
Vertex Corp. is currently trading at ¥1,409. View real-time AI analysis on Alpha Lenz.
What is Vertex Corp. insider trading activity?
View the latest insider trading data for Vertex Corp. on Alpha Lenz.
What is Vertex Corp.'s P/E ratio?
Vertex Corp.'s P/E ratio is 14.8.
Vertex Corp.
JPX · 5290“Vertex Corp. trades at a P/E of 14.8 (undervalued) with solid ROE of 13.7%.”
Ask for details →Company Overview
Vertex Corp. is a prominent player in the biotechnology sector, specifically focusing on the research, development, and commercialization of transformative therapies for serious diseases. Known for its cutting-edge approach in the realm of genetic therapies, Vertex has made significant strides in treating cystic fibrosis, a life-threatening genetic disorder. The company’s innovative drug portfolio caters to unmet medical needs, often pushing boundaries in medical research and development. With strategic research centers located globally, Vertex Corp. collaborates extensively with academic, industry, and healthcare partners to enhance the development pipeline. This commitment to cultivating a robust research ecosystem underscores its market significance. By continually seeking advancements in medicine, Vertex plays a crucial role in the healthcare landscape, impacting not just the life sciences industry but also the broader pharmaceutical market.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Vertex Corp. trades at a P/E of 14.8 (undervalued) with solid ROE of 13.7%.”
Ask for details →Frequently Asked Questions
Vertex Corp. (ticker: 5290) is a company listed on JPX in the Basic Materials sector (Building Materials). It has approximately 1,031 employees. Market cap is $71.4B.
The current price is 1,409 with a P/E ratio of 14.79x and P/B of 1.95x.
ROE is 13.71% and operating margin is 16.15%. Annual revenue is $38.9B.